A brief systems view of immunoregulation Over the past decade, the emerging discipline of systems biology has included a strong emphasis on network architecture and control mechanisms 14 . One subdiscipline is the area of synthetic biology, in which investigators seek to create predictable biological outcomes from molecular or genetic circuits not found in nature 15 . In attempting to program such pathogen replication 1, 2 , sacrificing host elements in the process; they use proteases that attack microbes but that also damage host constituents 3 ; they produce reactive oxygen species that are toxic not just for bacteria or some protozoa but also for self components [4] [5] [6] [7] ; and so on. Thus, there will always be some amount of collateral tissue damage during a response to infection; the trick is to limit this damage to just the amount needed to effectively clear (or maintain stasis of) the pathogen. In this context, the immune system acts according to a version of the physician's dictum of 'Do no harm' slightly modified to 'Do as little harm as possible. ' 7 Unfortunately, the problem that faces the immune system is much greater than the titration of its response to a clear foreign threat. Because of the nature of the generation of the T cell and B cell repertoire and the limits of central tolerance mechanisms, there is a constant risk of anti-self responses by cells of the adaptive immune system 8, 9 . Likewise, for innate effector cells, because they have evolved to deal with tissue damage as a source of signals that promote effector activity [10] [11] [12] , there is the risk that the cell disruption that occurs during an immune response or even as a result of abnormal tissue turnover 13 , will drive chronic and debilitating inflammatory responses if adequate suppressive controls are absent.
Previously published reviews and the Reviews in this Focus issue of Nature Immunology provide considerable detail about the molecular participants involved in the (neg-N ewton is well known for his three laws of motion. Newton's third law states that for every action there is always an opposite but equal reaction. This physical law can be rephrased to better suit an immunological perspective as follows: for every immunological stimulus or proinflammatory response, there is (are) one or more opposing control element(s). Such inhibitory activities can be cell intrinsic or extrinsic, they can act immediately or with variable time delay, they can be complete or partial, they can operate at the level of the gene, mRNA or protein and they can have varying spatial dimensions. However, they all share the common feature of providing the immune system with the ability to regulate the intensity, duration and scope of inflammatory processes that promote tissue repair or resistance to pathogens but can also damage the host.
The immune system is endowed with a wide diversity of effector modalities, whether soluble or cell mediated, innate or adaptive. Although antibodies can interfere with pathogen spread with only a limited effect on the function of host cells or tissues-through direct neutralization of viruses, for example-most effector processes provide anti-infective defense in an indirect manner. They remove infected cells through cytolytic mechanisms to decrease Maintaining system homeostasis: the third law of Newtonian immunology
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Because of the potent effector mechanisms of the immune system, the potential for self-destructive immune responses is especially high and many negative regulatory modalities exist to prevent excessive tissue damage. This Commentary places such regulatory mechanisms in the larger context of system organization on many scales. The sometimes counterintuitive nature of feedback control is discussed and a case is made for greater attention to quantitative spatiotemporal aspects of regulation, rather than limiting the discussion to the qualitative descriptions of pathways that dominate at present.
Ronald N. Germain is in the Lymphocyte Biology Section, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. e-mail: rgermain@nih.gov development or reactivation of effector cells 25 , although in the presence of inflammatory costimuli this cytokine can change its role from mediating such tonic suppression to contributing to the differentiation of effector cells 26 . T reg cells are also thought to act in a similar manner, indeed, in large measure through the same TGF-b pathway [27] [28] [29] . But a closer look suggests that there is a substantial difference between the two cases. The continuous production of bioactive TFG-b by nonhematopoietic elements in a tissue will suppress T cell activation and can serve as a threshold device that distinguishes engagement of T cell antigen receptors (TCRs) involving weak ligands (self ligands and pathogen-derived ligands that are a poor match for particular TCR in the repertoire) from those involving strong interactions. The former will be largely prevented from yielding full activation, whereas the latter will still drive the T cell beyond that threshold. TGF-b thus serves as a high-pass filter that eliminates 'noise' in the system; that is, undesired responses to weak inputs. In this specific case, it prevents responses to prevalent self ligands such as those that are involved in positive selection and are known to generate tonic signals through the TCRs of naive cells 30 while not substantially limiting responses to more avid (foreign) ligands. The tradeoff is a slight loss in sensitivity to small amounts of antigen for a large gain in avoiding chronic anti-self responses.
What about T reg cells? Do they not act in the same way? Here the answer is less clear. There are many studies showing that T reg cells often act after initial activation of T cells to suppress the development 31 or function 32 of effector cells rather than to prevent the initial activation itself, but most such studies have examso in the discussion that follows, the arguments that are presented apply across these scales even if couched in the specifics of a particular stratum of the system. A second essential point is the fundamental distinction between tonic regulators and reactive regulators that Murray and Smale make so cogently in their Focus Review 23 : the former set a threshold above which a stimulus must rise to elicit a response; the latter are reactive to the emerging response itself. In the former, the intent is to prevent an activity from occurring in the first place, whereas the latter seeks to limit the intensity or duration of the response once it has begun. These are unquestionably very distinct strategies of regulation, yet they are often not considered by immunologists describing the function of suppressive factors. However, each is closely related to the genetic subcircuits noted before 16 ; the tonic regulators act as noise filters that suppress undesired entry into the active state in the presence of nondangerous self stimuli 24 , whereas the reactive regulators fit in with those motifs that control the duration or timing of a response. It is readily apparent that there is less risk of collateral damage if activation of the immune response is prevented in the first place than if the system attempts to squelch an emerging response once it has begun ( Fig. 1) .
Did the tree fall in the forest? A more concrete example is that of two putatively tonic negative regulators of T cell immunological activity: the cytokine transforming growth factor-b (TGF-b) and regulatory T cells (T reg cells). TGF-b is present in an active form in many tissues and is believed to act continuously to raise the activation threshold of T cells to prevent weak self stimuli from driving the predefined activity, practitioners rely on analogies to electronic circuits and on seminal work describing the various ways in which small genetic circuits are organized to achieve specific functional outcomes, such as suppression of noise, signal amplification, delayed response, entrainment of a sequence of responses and so forth [16] [17] [18] [19] [20] . Such genetic motifs can be related to earlier descriptions of regulatory circuits in metabolic processes, some of which are highlighted in this Focus 21 . It is critical, however, to keep in mind that although such motifs can be identified in larger network structures, and understanding how these subcircuits each operate can be used to gain insight into the essential design principles of the system, overall biological function involves the integrated activity of these modules. Limitations on the understanding of how the immune system operates in health and disease often come from the assumption that a small 'worldview' of a few interacting elements can be used to adequately predict the outcome of a perturbation that in reality resonates throughout the organism 22 .
It is nonetheless still valuable to characterize, understand the apparent purpose of and place in context these limited mininetworks in the quest to develop a more comprehensive understanding of immunity. As a first step in relating emerging insights about subnetwork structure-function to negative immunological control, it is important to categorize the general properties of these regulatory pathways. One key insight is the fractal-like nature of regulation: the same strategies operate to provide inhibitory control within a cell, between cells and at a system-wide level. The specific molecular mediators vary at each level but the design of the regulatory circuits is conserved, Over time, the activity of a cell (blue line) will occasionally traverse (solid arrow) over the functional activation threshold. Here, T reg cells act in response to the initial activation to suppress the activated proto-effector cell back into the resting state after this initial activation response; this occurs repeatedly at times 1, 2 and 3. The potential for escape from control at any of these times is greater than that in a, in which TFG-b prevents supraactivation responses in the first place.
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Rethinking negative feedback control
Turning from control of self-reactivity to the avoidance of excessive inflammatory effector function in response to extrinsic stimuli, an important issue is how suppressive regulatory controls operate. It would be counterproductive for the immune system to completely prevent such responses, which are needed for host defense or wound healing. Thus, regulation must be reactive. This is typically thought of in terms of negative feedback responses that are graded in proportion to the input strength, but with a suitable time delay-basically the system just outlined for T reg cells and selfreactive T cells, but presumably with a longer time delay between initiation of the response and full operation of the inhibitory controls. The latter allows operation of the defense or healing mechanisms for an adequate period and then induces shutdown of these activities to avoid excess tissue damage. Examples of such regulation are detailed in the Reviews of this Focus and include signaling 'tolerance' to TLR ligands and the production of suppressive cytokines such as IL-10. Although the description above is a reasonable characterization of how such negative control circuits operate, it misses an important point. There is not merely a time delay in the operation of the negative regulatory elements but also a subtle yet critical kinetic aspect to the stimulus-response linkage in such cases. A strong, very sharply rising input will typically elicit a rapid and high-potency negative feedback that will truncate the response activity very quickly. The result is a 'spiky' output that Going one step further, spatial rather than just temporal considerations must be brought into the mix. Activation of T cells by self ligand presumably occurs rarely and at widely dispersed sites in secondary lymphoid tissues, based on a match (in terms of quality and amount) between the self ligand displayed on the presenting cells (dendritic cells) and the TCR specificity of the cells probing those dendritic cells. IL-2 will be produced locally in response to such engagement, so an adequate number of T reg cells will be required in the local vicinity to receive this signal and increase their suppressive capacity and/or outcompete the activated T cells for this cytokine 35 . T reg cells have an advantage over newly activated T cells for several hours in accessing and responding to the IL-2 because of their pre-existing expression of the IL-2 receptor CD25, but only if they are present within a small tissue volume near the activated proto-effector cells 36 . The surprising observation of transcription factors shared by effector T cells and T reg cells that drive expression of the same chemokine receptors is probably related to ensuring such colocalization, at least during the suppression of effector cells [37] [38] [39] [40] [41] . Furthermore, other data suggest that T reg cells are more suppressive if their TCRs are engaged. If they also must react with self ligands whose distribution is heterogeneous on individual dendritic cells, then how often will there be a match on the same dendritic cell between the ligand presented to T reg cells and that presented to the self-reactive effector cells? Thus, the spatial distribution of both IL-2 and TCR ligands will affect the operation of this control system, in contrast to the operation of one in which a dense network of stromal cells produces TGF-b so that all cells will be within ined responses to foreign antigens and not self ligands. Perhaps in terms of self-reactivity, these inhibitory cells do act as a tonic threshold filter, like tissue TGF-b; there is some evidence that supports this view 33 . However, close examination suggests a more nuanced picture. T reg cells exist in states of low and high activity, in large measure related to exposure to interleukin 2 (IL-2) 34 . In the steady state (in the absence of infection), such IL-2 is most likely to come from those T cells with the strongest remaining selfreactivity after thymic negative selection trims the repertoire. But those T cells will make IL-2 only after they have reached a level of TCR stimulus beyond the triggering threshold. This means that the T reg cells are not tonic suppressors of T cell activation but instead are feedback regulators whose activity depends on the output of the cells being controlled and whose inhibitory function follows with a time delay the initial activation of the target cells. Considered broadly, the T reg cells do prevent autoreactive T cell responses, but at a fine-grained level, their true mode of operation is to tamp down a response that has already been initiated. Mechanistically, there is a world of difference between true tonic inhibition that prevents a response from exceeding an activation threshold and a reactive negative-feedback regulation that must constrain a response already in motion. As the title of this section suggests, if observers do not listen carefully enough, they may not notice the tree falling, but that does not mean it did not happen. Just because the transient activation responses of autoreactive cells are not measured does not mean they do not regularly occur even with T reg cells present, with the attendant risks of a control mechanism operating after a response has already begun. . If a T reg cell is nearby, it can bind IL-2 and remove it from the region, becoming activated in the process and further mediating suppressive effects that limit the response of the proto-effector cell. (c) If a T reg cell is not positioned near the proto-effector cell, then activation and clonal expansion could continue. This is in contrast to the volume-encompassing suppressive effect of tissue TGF-b described in a.
Debbie Maizels c O m m e n Ta r y npg terms of how the robustness of an early increase in the signal affects the feedback regulation. The relocation of CTLA-4 from an intracellular pool to the surface membrane at the immunological synapse is controlled by the strength of TCR signaling 48 and, in a counterintuitive manner, such linkage results in greater suppression of a strong response than of a weaker one, which apparently serves to preserve the polyclonality of the T cell response and prevent easy escape by the pathogen via mutation 49 . PD-1 expression is also highest on the most antigen-reactive T cells, and reversal of PD-1 inhibition in chronically infected animals tends to allow the re-emergence of active effector cells from among subdominant responses rather than from among T cells reactive with immunodominant determinants 50 .
The larger context
This Commentary has only scratched the surface of the complexities inherent in the regulation of a network with as many 'moving parts' as the immune system. A smaller array of homeostatic controls may work for tissues with more predictable stresses but may prove inadequate for the immune system because of the extremely heterogeneous nature and timing of the challenges it faces. I have concentrated on the following few key issues among many important ones: the distinction between tonic and induced regulation, and the ease with which the latter can be confused with the former without explicit experiments designed to test whether the regulation is reactive or pre-existing; the insufficiently examined roles of spatial aspects of the organization of tissues of the immune system; and the counterintuitive nature of negative feedback control of strong versus weak responses. Only hints can be gleaned about the emergent properties of systems that cannot be discovered by analyses restricted to only very small parts of the larger whole. Deeper understanding of how the immune system achieves a balance between useful activity and a limitation of response-induced host damage will depend on the placement of the detailed but isolated observations typically made in individual studies into a more complete framework and the development of methods for predicting the activity of this more complex network when it is perturbed. the feed-forward potential of the circuit will not be realized. One could assume that the immune system is geared to generate strong responses to acute insults and, furthermore, to rapidly attenuate those strong responses to protect tissue integrity. In a system structured that way, the more slowly paced stimulation by some infectious agents that do not undergo explosive reproduction, or weak self-reactions that exceed tonic or local feedback controls, could 'slip under the radar' of those kinetically tuned regulatory mechanisms. The more prolonged nature of such responses due to the slow imposition of negative feedback control could represent the first step in the establishment of a chronic state of immune activity to the pathogen or self component. The preceding discussion did not make the distinction between controls that operate within a cell and those that operate from the outside or that are a combination of the two. The immune system uses all these possibilities. Cbl-b is one example of a cell-intrinsic regulator, and many other ubiquitin-ligases fall into this category 46 . CTLA-4 and PD-1 on T cells are cell-intrinsic negative regulators whose operation depends on cell-extrinsic cues in the form of counter-ligands on other cells 47 . Those counter-ligands concentrate the negative regulatory molecules near the site of TCR engagement at the T cell-antigen-presenting cell interface, which allows them to interfere with productive signaling from the TCR into the cell 48 . For both CTLA-4 and PD-1, the considerations presented above seem to apply in corresponds to a high peak of short duration 42 . This is in contrast to the activity seen with a slowly rising input, which elicits slower and less-robust feedback and permits a longer duration of response activity with a lower peak height (Fig. 3) . Different biological systems interpret the parameters of peak signal, signal duration above threshold and total signal in very distinct ways. Many biological circuits operate as concatenations of immediate-early, early and late gene responses. The last often depend on an initial biochemical activity that is sustained until after the immediate-early gene products are generated because these products are also substrates of that early enzymatic activity. Only when both activated signaling molecules and immediate-early gene products are both present at the same time can the response continue its course 43 . One example involves mitogen-activated protein kinases (MAPKs) and the transcription factor c-Fos; the gene that encodes the latter is under control of the transcription activator AP-1, of which c-Fos is one component and whose function depends on phosphorylation by MAPKs. The new pool of c-Fos induced by an initial activation of MAPKs appears only after 30 minutes of sequential gene induction, transcription and translation. If MAPK activity is extinguished before this new pool of substrate is produced, the new c-Fos cannot contribute to further AP-1 function 44, 45 . Thus, if strong initial activation of MAPKs elicits a rapid shutdown of its own activity through, for example, induction of the phosphatase DUSP 43 , then
Signaling intensity
Strong stimulus Weak stimulus Time Figure 3 In many signaling systems, a strong stimulus results in strong and rapid induction of negative feedback pathways that quickly suppress the signaling response. The result is a spiked response with a high peak but short duration. This is in contrasts to a weaker stimulus that reaches a lower peak of signaling but in which the response is sustained because of slower and less-robust induction of the negative feedback pathway. Because of the way immediate-early and early gene-transcription programs are kinetically linked to signaling inputs, these two different outcomes of stimulation of the cell can lead to very different downstream effects.
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